Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Equity Ratio: 2018-2025

Historic Equity Ratio for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to 0.81.

  • Bicycle Therapeutics' Equity Ratio fell 2.90% to 0.81 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.81, marking a year-over-year decrease of 2.90%. This contributed to the annual value of 0.83 for FY2024, which is 33.02% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Equity Ratio stood at 0.81, which was up 0.72% from 0.80 recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Equity Ratio high stood at 0.84 for Q1 2025, and its period low was 0.48 during Q2 2023.
  • Its 3-year average for Equity Ratio is 0.72, with a median of 0.80 in 2025.
  • In the last 5 years, Bicycle Therapeutics' Equity Ratio slumped by 30.67% in 2023 and then surged by 70.53% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Equity Ratio (Quarterly) stood at 0.72 in 2021, then decreased by 8.62% to 0.66 in 2022, then decreased by 5.52% to 0.62 in 2023, then soared by 33.02% to 0.83 in 2024, then dropped by 2.90% to 0.81 in 2025.
  • Its Equity Ratio stands at 0.81 for Q3 2025, versus 0.80 for Q2 2025 and 0.84 for Q1 2025.